Lusomedicamenta - Sociedade Técnica Farmacêutica S.A., a subsidiary company of Recipharm AB (publ), incorporated under Portuguese Law and with experience in the pharmaceutical sector, on the sale of the shares representing 100% of its subsidiary “DAVI II Farmacêutica, S.A.”, a company that specialises in ophthalmic products, to a private buyer.
Target: “DAVI II Farmacêutica, S.A.”, a company that specialises in ophthalmic products and is focused on the import and distribution of pharmaceutical and cosmetic and similar products, and the import and distribution of hospital, clinical and laboratory related materials and equipment.
Target Industry:
HEALTH CARE
PHARMACEUTICALS & LIFE SCIENCES
Country of Target: Portugal
Sellers (%) – Country: Lusomedicamenta - Sociedade Técnica Farmacêutica S.A.|Sweden / Portugal
Purchaser/Investor (%) – Country: Laboratório Medinfar - Produtos Farmacêuticos
| Portugal
Deal Value (in local currency): the purchase price for DAVI amounts to approximately EUR 5 million.
Financial Advice: N/A
Legal Advice: Adviser (Parties Advised):
VdA – Advised Lusomedicamenta - Sociedade Técnica Farmacêutica S.A.
F. Castelo Branco & Associados - Sociedade de Advogados, SP, RL – Advised Laboratório Medinfar -
Produtos Farmacêuticos
VdA Team Involved:
Rita Marques (Senior Adviser, M&A)
Francisca Paulouro (Of Counsel, Life Sciences)
Tiago Piló (Managing Associate, Labour)
Vanessa Cardoso Pires (Managing Associate, Corporate Services Unit)
Pedro Fontes (Senior Associate, Life Sciences)
Isa Rodrigues (Associate, M&A)
João Francisco Barreiros (Asscociate, C&EU)
Philippa Soares Franco (Associate, M&A)
Marta Stock da Cunha (Junior Associate, Energy & Natural Resources)
Press Release / Links: